Kim BJ - Search Results

1

Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer.

Kim CG, Jung M, Kim HS, Lee CK, Jeung HC, Koo DH, Bae WK, Zang DY, Kim BJ, Kim H, Yun UJ, Che J, Park S, Kim TS, Kwon WS, Park J, Cho SW, Nam CM, Chung HC, Rha SY. Kim CG, et al. Among authors: kim ts, kim h, kim bj, kim hs. J Clin Oncol. 2023 Sep 20;41(27):4394-4405. doi: 10.1200/JCO.22.02122. Epub 2023 Jun 26. J Clin Oncol. 2023. PMID: 37364218

2

Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review.

Kim BJ, Kim JH, Kim HS, Zang DY. Kim BJ, et al. Among authors: kim hs, kim jh. Oncotarget. 2017 Feb 21;8(8):13979-13985. doi: 10.18632/oncotarget.14704. Oncotarget. 2017. PMID: 28103578 Free PMC article. Review.

3

Tivantinib inhibits the VEGF signaling pathway and induces apoptosis in gastric cancer cells with c-MET or VEGFA amplification.

Kim BJ, Kim YJ, Sohn SH, Kim B, Sul HJ, Kim HS, Zang DY. Kim BJ, et al. Among authors: kim yj, kim b, kim hs. Invest New Drugs. 2020 Dec;38(6):1633-1640. doi: 10.1007/s10637-020-00940-3. Epub 2020 May 2. Invest New Drugs. 2020. PMID: 32361789

4

Tepotinib Inhibits the Epithelial-Mesenchymal Transition and Tumor Growth of Gastric Cancers by Increasing GSK3β, E-Cadherin, and Mucin 5AC and 6 Levels.

Sohn SH, Sul HJ, Kim B, Kim BJ, Kim HS, Zang DY. Sohn SH, et al. Among authors: kim b, kim bj, kim hs. Int J Mol Sci. 2020 Aug 21;21(17):6027. doi: 10.3390/ijms21176027. Int J Mol Sci. 2020. PMID: 32825724 Free PMC article.

5

A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.

Han B, Kim BJ, Kim HS, Choi DR, Shim BY, Lee KH, Kim JW, Kim JH, Song H, Kim JH, Park CK, Lee JW, Kim MJ, Zang DY. Han B, et al. Among authors: kim bj, kim hs, kim jw, kim mj, kim jh. J Cancer. 2021 Jan 1;12(3):912-917. doi: 10.7150/jca.50514. eCollection 2021. J Cancer. 2021. PMID: 33403047 Free PMC article.

6

RNF43 and PWWP2B inhibit cancer cell proliferation and are predictive or prognostic biomarker for FDA-approved drugs in patients with advanced gastric cancer.

Sohn SH, Sul HJ, Kim B, Kim HS, Kim BJ, Lim H, Kang HS, Soh JS, Kim KC, Cho JW, Seo J, Koh Y, Zang DY. Sohn SH, et al. Among authors: kim b, kim bj, kim kc, kim hs. J Cancer. 2021 Jun 1;12(15):4616-4625. doi: 10.7150/jca.56014. eCollection 2021. J Cancer. 2021. PMID: 34149925 Free PMC article.

7

Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).

Han HS, Kim BJ, Jee HJ, Ryu MH, Park SH, Rha SY, Kim JG, Bae WK, Lee KW, Oh DY, Kim IH, Sym SJ, Oh SY, Kim HS, Byun JH, Kim DS, Suh YJ, An H, Zang DY. Han HS, et al. Among authors: kim ih, kim ds, kim bj, kim hs, kim jg. Ther Adv Med Oncol. 2021 Sep 18;13:17588359211042812. doi: 10.1177/17588359211042812. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34552667 Free PMC article.

8

TRK inhibitors block NFKB and induce NRF2 in TRK fusion-positive colon cancer.

Sohn SH, Sul HJ, Kim B, Kim BJ, Kim HS, Zang DY. Sohn SH, et al. Among authors: kim b, kim bj, kim hs. J Cancer. 2021 Aug 28;12(21):6356-6362. doi: 10.7150/jca.60845. eCollection 2021. J Cancer. 2021. PMID: 34659525 Free PMC article.

9

Entrectinib Induces Apoptosis and Inhibits the Epithelial-Mesenchymal Transition in Gastric Cancer with NTRK Overexpression.

Sohn SH, Sul HJ, Kim BJ, Kim HS, Zang DY. Sohn SH, et al. Among authors: kim bj, kim hs. Int J Mol Sci. 2021 Dec 30;23(1):395. doi: 10.3390/ijms23010395. Int J Mol Sci. 2021. PMID: 35008821 Free PMC article.

10

Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16).

Kim BJ, Jee HJ, Rha SY, Han HS, Ryu MH, Park SH, Kim JG, Bae WK, Lee KW, Oh DY, Byun JH, Kim DS, Suh YJ, An H, Zang DY. Kim BJ, et al. Among authors: kim ds, kim jg. Gastric Cancer. 2022 May;25(3):609-618. doi: 10.1007/s10120-021-01276-4. Epub 2022 Jan 11. Gastric Cancer. 2022. PMID: 35015188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,994 results

Search Page